Pranlukast-d4 structure
|
Common Name | Pranlukast-d4 | ||
---|---|---|---|---|
CAS Number | 2713172-43-9 | Molecular Weight | 485.53 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C27H19D4N5O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Pranlukast-d4Pranlukast-d4 is deuterium labeled Pranlukast. Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [3H]LTE4, [3H]LTD4, and [3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively. |
Name | Pranlukast-d4 |
---|
Description | Pranlukast-d4 is deuterium labeled Pranlukast. Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [3H]LTE4, [3H]LTD4, and [3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C27H19D4N5O4 |
---|---|
Molecular Weight | 485.53 |